Biotechnology
The Biotechnology industry has a total of 586 stocks, with a combined market cap of $1.25 trillion and total revenue of $109.76 billion.
Market Cap
1.25T
Revenue
109.76B
Profits
-41.37B
PE Ratio
n/a
Profit Margin
-37.69%
Dividend Yield
0.04%
586 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 121.09B | 0.16% | 1,192,070 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 67.60B | 1.27% | 555,420 | 14.92B |
| 3 | ARGX | argenx SE | 53.71B | 0.41% | 177,219 | 4.74B |
| 4 | RVMD | Revolution Medicines, Inc. | 39.21B | -0.29% | 1,538,128 | - |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.27B | -0.75% | 1,284,941 | 4.29B |
| 6 | ONC | BeOne Medicines AG | 34.60B | 1.53% | 636,544 | 5.74B |
| 7 | RPRX | Royalty Pharma plc | 32.43B | 1.15% | 2,749,372 | 2.44B |
| 8 | MRNA | Moderna, Inc. | 27.09B | 1.25% | 3,427,826 | 2.23B |
| 9 | ROIV | Roivant Sciences Ltd. | 25.10B | -0.06% | 2,555,835 | 8.26M |
| 10 | INSM | Insmed Incorporated | 23.80B | -0.27% | 2,116,814 | 819.56M |
| 11 | BNTX | BioNTech SE | 23.26B | 1.76% | 761,876 | 3.23B |
| 12 | INCY | Incyte Corporation | 22.99B | 0.18% | 1,564,845 | 5.36B |
| 13 | GMAB | Genmab A/S | 17.81B | 1.22% | 1,744,239 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 16.68B | 1.13% | 441,977 | 998.25M |
| 15 | BBIO | BridgeBio Pharma, Inc. | 16.20B | -1.70% | 1,955,282 | 579.96M |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 15.03B | 0.53% | 610,536 | 4.44B |
| 17 | EXEL | Exelixis, Inc. | 13.96B | -0.39% | 1,895,910 | 2.38B |
| 18 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.69B | 2.49% | 264,310 | 1.13B |
| 19 | AXSM | Axsome Therapeutics, Inc. | 12.22B | 0.96% | 838,870 | 708.24M |
| 20 | ABVX | ABIVAX Société Anonyme | 11.81B | 1.50% | 934,624 | 5.67M |
| 21 | SMMT | Summit Therapeutics Inc. | 11.70B | -2.59% | 2,302,869 | - |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 11.39B | 0.53% | 908,054 | 3.24B |
| 23 | CYTK | Cytokinetics, Incorporated | 11.22B | 0.84% | 1,334,079 | 105.82M |
| 24 | TECH | Bio-Techne Corporation | 11.14B | 0.35% | 3,187,304 | 1.21B |
| 25 | KRYS | Krystal Biotech, Inc. | 10.32B | 3.18% | 381,177 | 417.30M |
| 26 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.12B | -0.13% | 1,863,849 | 622.01M |
| 27 | APGE | Apogee Therapeutics, Inc. | 10.06B | 0.25% | 607,392 | - |
| 28 | NUVL | Nuvalent, Inc. | 9.83B | - | - | - |
| 29 | CORT | Corcept Therapeutics Incorporated | 9.62B | -0.99% | 1,019,944 | 769.10M |
| 30 | KYMR | Kymera Therapeutics, Inc. | 9.39B | 1.82% | 414,654 | 51.48M |
| 31 | IONS | Ionis Pharmaceuticals, Inc. | 9.04B | -0.36% | 3,577,546 | 1.06B |
| 32 | HALO | Halozyme Therapeutics, Inc. | 8.99B | 1.03% | 1,339,964 | 1.51B |
| 33 | SYRE | Spyre Therapeutics, Inc. | 8.98B | 3.15% | 1,520,637 | - |
| 34 | PRAX | Praxis Precision Medicines, Inc. | 8.88B | -2.83% | 253,559 | 7.46M |
| 35 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.85B | 0.23% | 3,531,274 | 18.07M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 8.71B | 3.19% | 836,109 | 74.06M |
| 37 | PCVX | Vaxcyte, Inc. | 8.19B | 0.94% | 857,074 | - |
| 38 | IMVT | Immunovant, Inc. | 8.19B | 2.86% | 754,954 | - |
| 39 | IBRX | ImmunityBio, Inc. | 8.10B | -1.90% | 6,702,001 | 140.98M |
| 40 | TGTX | TG Therapeutics, Inc. | 8.00B | 2.77% | 1,615,954 | 700.35M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.52B | -0.25% | 404,361 | 217.17M |
| 42 | MIRM | Mirum Pharmaceuticals, Inc. | 7.38B | 0.09% | 316,557 | 569.61M |
| 43 | COGT | Cogent Biosciences, Inc. | 6.72B | 2.05% | 2,172,489 | - |
| 44 | ERAS | Erasca, Inc. | 6.61B | 9.03% | 9,044,043 | - |
| 45 | XENE | Xenon Pharmaceuticals Inc. | 6.55B | 0.61% | 772,030 | 7.50M |
| 46 | PTCT | PTC Therapeutics, Inc. | 6.54B | 1.00% | 1,357,110 | 827.11M |
| 47 | SRRK | Scholar Rock Holding Corporation | 6.48B | 0.48% | 551,859 | - |
| 48 | CGON | CG Oncology, Inc. | 6.44B | 1.71% | 1,328,737 | 5.07M |
| 49 | DFTX | Definium Therapeutics, Inc. | 6.06B | -0.70% | 1,436,987 | - |
| 50 | BLTE | Belite Bio, Inc | 5.88B | 1.90% | 102,801 | - |
| 51 | LGND | Ligand Pharmaceuticals Incorporated | 5.87B | -1.56% | 291,126 | 274.48M |
| 52 | DNTH | Dianthus Therapeutics, Inc. | 5.46B | -1.35% | 813,826 | 1.34M |
| 53 | TVTX | Travere Therapeutics, Inc. | 5.28B | -0.56% | 801,487 | 536.20M |
| 54 | ORKA | Oruka Therapeutics, Inc. | 5.23B | -0.94% | 825,226 | - |
| 55 | MANE | Veradermics, Incorporated | 5.17B | 12.28% | 1,338,019 | - |
| 56 | CRSP | CRISPR Therapeutics AG | 5.06B | 1.80% | 1,318,800 | 4.10M |
| 57 | CAI | Caris Life Sciences, Inc. | 4.94B | 3.01% | 6,453,492 | 907.29M |
| 58 | CELC | Celcuity Inc. | 4.46B | -17.60% | 8,750,376 | - |
| 59 | LEGN | Legend Biotech Corporation | 4.46B | -10.25% | 5,222,450 | 1.14B |
| 60 | ACAD | ACADIA Pharmaceuticals Inc. | 4.44B | 1.69% | 1,274,099 | 1.10B |
| 61 | EWTX | Edgewise Therapeutics, Inc. | 4.39B | 2.77% | 1,107,014 | - |
| 62 | VKTX | Viking Therapeutics, Inc. | 4.39B | -0.42% | 1,228,471 | - |
| 63 | TNGX | Tango Therapeutics, Inc. | 4.38B | 2.02% | 2,278,840 | 56.99M |
| 64 | RLAY | Relay Therapeutics, Inc. | 4.25B | 2.25% | 1,538,023 | 10.68M |
| 65 | DYN | Dyne Therapeutics, Inc. | 3.97B | 0.88% | 1,253,633 | - |
| 66 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | - | - | 596.96M |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.81B | 2.45% | 61,910 | 803.79M |
| 68 | PBLS | Parabilis Medicines, Inc. | 3.81B | -3.98% | 463,819 | - |
| 69 | NAMS | NewAmsterdam Pharma Company N.V. | 3.74B | -3.94% | 1,035,329 | 22.57M |
| 70 | ELVN | Enliven Therapeutics, Inc. | 3.71B | 2.76% | 500,760 | - |
| 71 | ALMS | Alumis Inc. | 3.67B | 5.61% | 1,495,227 | 8.40M |
| 72 | DNLI | Denali Therapeutics Inc. | 3.65B | 1.63% | 1,889,604 | - |
| 73 | GPCR | Structure Therapeutics Inc. | 3.53B | -1.92% | 684,483 | - |
| 74 | RCUS | Arcus Biosciences, Inc. | 3.52B | -1.09% | 718,652 | 236.00M |
| 75 | IDYA | IDEAYA Biosciences, Inc. | 3.49B | 0.25% | 580,359 | 225.27M |
| 76 | ARQT | Arcutis Biotherapeutics, Inc. | 3.47B | 3.62% | 1,508,331 | 415.62M |
| 77 | RARE | Ultragenyx Pharmaceutical Inc. | 3.11B | -1.00% | 1,012,611 | 670.00M |
| 78 | BEAM | Beam Therapeutics Inc. | 3.07B | -0.16% | 1,395,268 | 164.01M |
| 79 | VERA | Vera Therapeutics, Inc. | 3.05B | -1.46% | 1,802,157 | - |
| 80 | CLDX | Celldex Therapeutics, Inc. | 3.01B | 0.37% | 534,209 | 865.00K |
| 81 | IRON | Disc Medicine, Inc. | 2.90B | 1.35% | 262,389 | - |
| 82 | MBX | MBX Biosciences, Inc. | 2.89B | 7.22% | 1,078,723 | - |
| 83 | QURE | uniQure N.V. | 2.82B | -1.25% | 914,599 | 18.09M |
| 84 | KOD | Kodiak Sciences Inc. | 2.65B | -1.94% | 688,952 | - |
| 85 | IMNM | Immunome, Inc. | 2.60B | 1.46% | 1,899,273 | 4.02M |
| 86 | TRVI | Trevi Therapeutics, Inc. | 2.58B | 1.31% | 1,910,604 | - |
| 87 | SLS | SELLAS Life Sciences Group, Inc. | 2.51B | -4.48% | 6,859,911 | - |
| 88 | KLRA | Kailera Therapeutics, Inc. | 2.50B | 1.53% | 285,931 | - |
| 89 | NRIX | Nurix Therapeutics, Inc. | 2.48B | 3.79% | 1,087,611 | 36.77M |
| 90 | TARS | Tarsus Pharmaceuticals, Inc. | 2.47B | 2.48% | 1,467,065 | 535.08M |
| 91 | PHVS | Pharvaris N.V. | 2.46B | 2.15% | 234,437 | - |
| 92 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | 0.11% | 502,433 | - |
| 93 | VCEL | Vericel Corporation | 2.39B | 1.37% | 318,929 | 292.09M |
| 94 | AGIO | Agios Pharmaceuticals, Inc. | 2.37B | -0.13% | 625,036 | 66.05M |
| 95 | MESO | Mesoblast Limited | 2.35B | 8.96% | 488,616 | 65.38M |
| 96 | NKTR | Nektar Therapeutics | 2.31B | 1.68% | 543,480 | 55.63M |
| 97 | ZLAB | Zai Lab Limited | 2.30B | 5.91% | 959,584 | 453.28M |
| 98 | BHVN | Biohaven Ltd. | 2.24B | -0.54% | 1,310,885 | - |
| 99 | OCUL | Ocular Therapeutix, Inc. | 2.18B | 2.68% | 1,322,841 | 52.04M |
| 100 | PVLA | Palvella Therapeutics, Inc. | 2.18B | 1.53% | 189,671 | - |
| 101 | IOVA | Iovance Biotherapeutics, Inc. | 2.12B | 20.61% | 43,697,871 | 285.61M |
| 102 | VRDN | Viridian Therapeutics, Inc. | 2.10B | -0.10% | 1,578,694 | 70.92M |
| 103 | SNDX | Syndax Pharmaceuticals, Inc. | 2.08B | -2.53% | 2,282,986 | 217.17M |
| 104 | AUPH | Aurinia Pharmaceuticals Inc. | 2.07B | 0.75% | 951,748 | 298.30M |
| 105 | ABCL | AbCellera Biologics Inc. | 2.06B | - | 3,752,391 | 79.21M |
| 106 | NUVB | Nuvation Bio Inc. | 2.05B | - | 4,540,992 | 143.05M |
| 107 | COAG | Hemab Therapeutics Holdings, Inc. | 2.02B | 0.02% | 307,357 | - |
| 108 | HRMY | Harmony Biosciences Holdings, Inc. | 2.02B | 0.26% | 802,722 | 899.11M |
| 109 | NBTX | Nanobiotix S.A. | 2.02B | -4.03% | 104,563 | 38.27M |
| 110 | ADMA | ADMA Biologics, Inc. | 2.01B | -2.14% | 2,140,514 | 509.86M |
| 111 | SION | Sionna Therapeutics, Inc. | 2.00B | 4.20% | 522,135 | - |
| 112 | TSHA | Taysha Gene Therapies, Inc. | 1.98B | 8.60% | 5,210,751 | 7.47M |
| 113 | GLUE | Monte Rosa Therapeutics, Inc. | 1.98B | -0.21% | 842,628 | 42.95M |
| 114 | ATAI | AtaiBeckley Inc. | 1.97B | -5.47% | 10,867,550 | 3.49M |
| 115 | KARD | Kardigan, Inc. | 1.96B | -1.21% | 334,984 | - |
| 116 | LKFT | Lakefront Biotherapeutics NV | 1.94B | 0.03% | 81,656 | 1.20B |
| 117 | URGN | UroGen Pharma Ltd. | 1.94B | 1.56% | 907,828 | 140.49M |
| 118 | TYRA | Tyra Biosciences, Inc. | 1.93B | -1.52% | 388,744 | - |
| 119 | RAPP | Rapport Therapeutics, Inc. | 1.91B | -3.69% | 256,353 | 20.00M |
| 120 | DMRA | Damora Therapeutics, Inc. | 1.91B | -0.13% | 622,554 | - |
| 121 | STOK | Stoke Therapeutics, Inc. | 1.86B | 2.68% | 592,391 | 32.08M |
| 122 | SRPT | Sarepta Therapeutics, Inc. | 1.86B | -1.95% | 3,508,810 | 2.18B |
| 123 | ZBIO | Zenas BioPharma, Inc. | 1.86B | 2.19% | 611,262 | 10.00M |
| 124 | BCAX | Bicara Therapeutics Inc. | 1.85B | 0.05% | 258,745 | - |
| 125 | GHRS | GH Research PLC | 1.85B | 0.56% | 141,067 | - |
| 126 | AAPG | Ascentage Pharma Group International | 1.83B | 4.89% | 15,406 | 82.08M |
| 127 | PGEN | Precigen, Inc. | 1.83B | - | 1,917,884 | 31.60M |
| 128 | NTLA | Intellia Therapeutics, Inc. | 1.82B | -1.95% | 4,026,083 | 66.09M |
| 129 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.82B | 8.14% | 4,808,483 | 204.73M |
| 130 | GENB | Generate Biomedicines, Inc. | 1.80B | -0.99% | 664,494 | 30.30M |
| 131 | ZYME | Zymeworks Inc. | 1.77B | - | 326,274 | 81.26M |
| 132 | IMCR | Immunocore Holdings plc | 1.76B | 3.62% | 523,626 | 412.81M |
| 133 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | -0.90% | 19,429,100 | 66.41M |
| 134 | FTRE | Fortrea Holdings Inc. | 1.69B | -0.67% | 974,023 | 2.71B |
| 135 | MPLT | MapLight Therapeutics, Inc. | 1.69B | -1.53% | 703,072 | - |
| 136 | ABSI | Absci Corporation | 1.65B | -4.59% | 3,438,584 | 1.84M |
| 137 | ANAB | AnaptysBio, Inc. | 1.65B | -10.70% | 1,546,208 | 232.39M |
| 138 | MLTX | MoonLake Immunotherapeutics | 1.65B | 2.25% | 1,004,731 | - |
| 139 | MAZE | Maze Therapeutics, Inc. | 1.63B | -1.64% | 346,803 | 20.00M |
| 140 | VIR | Vir Biotechnology, Inc. | 1.62B | 1.26% | 1,225,213 | 65.50M |
| 141 | INVA | Innoviva, Inc. | 1.62B | 0.69% | 1,016,600 | 420.69M |
| 142 | SEPN | Septerna, Inc. | 1.54B | -1.36% | 373,683 | 72.26M |
| 143 | AVBP | ArriVent BioPharma, Inc. | 1.53B | 1.26% | 314,967 | - |
| 144 | SVRA | Savara Inc. | 1.47B | 2.11% | 1,035,544 | - |
| 145 | AKTS | Aktis Oncology, Inc. | 1.44B | 3.26% | 435,520 | 8.28M |
| 146 | NVAX | Novavax, Inc. | 1.39B | 0.12% | 2,537,760 | 596.34M |
| 147 | INBX | Inhibrx Biosciences, Inc. | 1.34B | -2.13% | 208,419 | 1.30M |
| 148 | ARDX | Ardelyx, Inc. | 1.31B | 2.71% | 2,669,684 | 427.68M |
| 149 | JBIO | Jade Biosciences, Inc. | 1.30B | 2.44% | 804,005 | - |
| 150 | IMTX | Immatics N.V. | 1.29B | 1.28% | 477,292 | 43.00M |
| 151 | MNKD | MannKind Corporation | 1.26B | 5.41% | 5,611,450 | 360.78M |
| 152 | TRAX | First Tracks Biotherapeutics, Inc. | 1.26B | 5.12% | 486,913 | - |
| 153 | CRVS | Corvus Pharmaceuticals, Inc. | 1.25B | -0.33% | 878,139 | - |
| 154 | AVLN | Avalyn Pharma Inc. | 1.21B | -3.11% | 232,142 | - |
| 155 | CAPR | Capricor Therapeutics, Inc. | 1.18B | -1.60% | 1,371,340 | 11.13M |
| 156 | MGTX | MeiraGTx Holdings plc | 1.16B | 0.96% | 632,032 | 79.76M |
| 157 | EYPT | EyePoint, Inc. | 1.16B | 0.87% | 1,484,510 | 7.61M |
| 158 | ORIC | ORIC Pharmaceuticals, Inc. | 1.15B | 5.59% | 1,778,133 | - |
| 159 | WVE | Wave Life Sciences Ltd. | 1.14B | -3.59% | 1,418,186 | 71.80M |
| 160 | DRTS | Alpha Tau Medical Ltd. | 1.12B | 0.97% | 669,342 | - |
| 161 | XNCR | Xencor, Inc. | 1.11B | 0.20% | 487,640 | 97.36M |
| 162 | CGEM | Cullinan Therapeutics, Inc. | 1.10B | 0.34% | 505,152 | - |
| 163 | SPTX | Seaport Therapeutics, Inc. | 1.09B | 0.05% | 72,500 | - |
| 164 | ANRO | Alto Neuroscience, Inc. | 1.08B | 0.07% | 422,439 | - |
| 165 | FBRX | Forte Biosciences, Inc. | 1.08B | 2.20% | 631,370 | - |
| 166 | ANNX | Annexon, Inc. | 1.06B | 17.12% | 8,846,423 | - |
| 167 | SANA | Sana Biotechnology, Inc. | 1.06B | -0.56% | 2,116,311 | - |
| 168 | IVA | Inventiva S.A. | 1.05B | 1.59% | 984,952 | 7.94M |
| 169 | OLMA | Olema Pharmaceuticals, Inc. | 1.03B | -0.25% | 958,161 | - |
| 170 | KURA | Kura Oncology, Inc. | 1.01B | 0.80% | 1,152,783 | 71.64M |
| 171 | VOR | Vor Biopharma Inc. | 979.68M | -2.27% | 767,740 | - |
| 172 | JANX | Janux Therapeutics, Inc. | 977.58M | 1.58% | 846,651 | 13.73M |
| 173 | LXRX | Lexicon Pharmaceuticals, Inc. | 977.23M | 3.77% | 4,408,666 | 69.64M |
| 174 | AVTX | Avalo Therapeutics, Inc. | 975.09M | 0.71% | 618,040 | 59.00K |
| 175 | SLDB | Solid Biosciences Inc. | 947.09M | -0.10% | 951,058 | - |
| 176 | PHAR | Pharming Group N.V. | 945.12M | -0.15% | 3,757 | 369.49M |
| 177 | DBVT | DBV Technologies S.A. | 935.50M | -1.32% | 142,942 | 5.74M |
| 178 | LBRX | LB Pharmaceuticals Inc | 922.24M | 0.44% | 108,168 | - |
| 179 | GERN | Geron Corporation | 910.96M | 2.90% | 6,178,428 | 196.12M |
| 180 | ABUS | Arbutus Biopharma Corporation | 900.77M | -1.08% | 1,507,577 | 191.45M |
| 181 | PHAT | Phathom Pharmaceuticals, Inc. | 877.70M | 0.09% | 899,527 | 204.89M |
| 182 | TBPH | Theravance Biopharma, Inc. | 877.45M | 0.06% | 615,439 | 109.78M |
| 183 | DSGN | Design Therapeutics, Inc. | 844.42M | -1.10% | 396,307 | - |
| 184 | ODTX | Odyssey Therapeutics, Inc. | 825.90M | -0.35% | 189,078 | 1.06M |
| 185 | REPL | Replimune Group, Inc. | 812.59M | -1.93% | 1,578,945 | - |
| 186 | FTH | Faeth Therapeutics, Inc. | 811.26M | -4.98% | 568,208 | - |
| 187 | CTMX | CytomX Therapeutics, Inc. | 801.15M | 0.55% | 5,145,798 | 35.54M |
| 188 | CLYM | Climb Bio, Inc. | 794.20M | 4.76% | 974,939 | - |
| 189 | OCS | Oculis Holding AG | 792.29M | 1.47% | 236,802 | 1.40M |
| 190 | NGNE | Neurogene Inc. | 786.12M | 0.95% | 181,688 | 925.00K |
| 191 | TENX | Tenax Therapeutics, Inc. | 783.75M | -1.41% | 979,815 | - |
| 192 | ACRS | Aclaris Therapeutics, Inc. | 782.12M | 3.13% | 6,078,070 | 8.37M |
| 193 | AURA | Aura Biosciences, Inc. | 773.20M | 0.14% | 308,838 | - |
| 194 | ZVRA | Zevra Therapeutics, Inc. | 766.13M | -0.77% | 871,759 | 122.29M |
| 195 | RIGL | Rigel Pharmaceuticals, Inc. | 761.92M | 0.02% | 224,187 | 299.77M |
| 196 | OMER | Omeros Corporation | 750.53M | -1.24% | 1,134,964 | 9.89M |
| 197 | SPRY | ARS Pharmaceuticals, Inc. | 749.74M | -0.79% | 1,838,410 | 98.99M |
| 198 | IMMX | Immix Biopharma, Inc. | 749.63M | -1.40% | 980,800 | - |
| 199 | DRUG | Bright Minds Biosciences Inc. | 741.29M | 2.55% | 297,385 | - |
| 200 | GYRE | Gyre Therapeutics, Inc. | 731.37M | 3.47% | 40,508 | 117.05M |
| 201 | MNPR | Monopar Therapeutics Inc. | 728.09M | 8.92% | 177,109 | - |
| 202 | CADL | Candel Therapeutics, Inc. | 706.33M | -2.33% | 1,158,298 | - |
| 203 | SGP | SpyGlass Pharma, Inc. | 688.73M | 3.05% | 146,386 | - |
| 204 | SLBT | SL Science Holding Limited | 685.29M | -3.42% | 62,258 | - |
| 205 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 673.70M | -4.65% | 468,279 | - |
| 206 | CRMD | CorMedix Inc. | 660.56M | 1.81% | 648,440 | 400.05M |
| 207 | ALLO | Allogene Therapeutics, Inc. | 655.79M | 2.70% | 6,039,901 | 22.00K |
| 208 | RLMD | Relmada Therapeutics, Inc. | 651.37M | - | 985,915 | - |
| 209 | ACHV | Achieve Life Sciences, Inc. | 649.83M | 0.32% | 1,669,082 | - |
| 210 | MDXG | MiMedx Group, Inc. | 636.00M | 1.67% | 1,206,576 | 389.42M |
| 211 | RGNX | REGENXBIO Inc. | 634.34M | -0.16% | 1,197,215 | 87.82M |
| 212 | PRME | Prime Medicine, Inc. | 630.35M | 0.58% | 2,538,027 | 4.03M |
| 213 | AGMB | AgomAb Therapeutics NV | 622.00M | 4.90% | 142,969 | - |
| 214 | NVCT | Nuvectis Pharma, Inc. | 617.59M | 7.11% | 212,762 | - |
| 215 | TECX | Tectonic Therapeutic, Inc. | 613.25M | -6.64% | 240,899 | - |
| 216 | FDMT | 4D Molecular Therapeutics, Inc. | 610.59M | -0.17% | 419,762 | 88.24M |
| 217 | DNA | Ginkgo Bioworks Holdings, Inc. | 587.92M | -0.44% | 607,204 | 151.40M |
| 218 | ALT | Altimmune, Inc. | 579.53M | 1.71% | 2,862,398 | 36.00K |
| 219 | CTNM | Contineum Therapeutics, Inc. | 546.96M | 0.41% | 150,986 | - |
| 220 | ARVN | Arvinas, Inc. | 534.24M | 0.12% | 471,812 | 89.40M |
| 221 | EIKN | Eikon Therapeutics, Inc. | 532.72M | -3.43% | 219,055 | - |
| 222 | ASMB | Assembly Biosciences, Inc. | 529.72M | -0.11% | 124,814 | 71.10M |
| 223 | CBIO | Crescent Biopharma, Inc. | 520.70M | 2.35% | 2,189,530 | 11.88M |
| 224 | STTK | Shattuck Labs, Inc. | 519.13M | 7.63% | 3,113,657 | 1.00M |
| 225 | ZURA | Zura Bio Limited | 512.04M | 6.52% | 690,318 | - |
| 226 | VSTM | Verastem, Inc. | 503.52M | 2.87% | 2,083,595 | 49.59M |
| 227 | RZLT | Rezolute, Inc. | 495.17M | -1.86% | 756,330 | - |
| 228 | SLN | Silence Therapeutics plc | 493.59M | 7.18% | 791,971 | 839.00K |
| 229 | SGMT | Sagimet Biosciences Inc. | 493.40M | 2.96% | 1,529,983 | - |
| 230 | OCGN | Ocugen, Inc. | 484.09M | - | 3,577,056 | 4.47M |
| 231 | PROK | ProKidney Corp. | 483.30M | 3.23% | 827,891 | 889.00K |
| 232 | ARTV | Artiva Biotherapeutics, Inc. | 481.99M | 6.10% | 456,242 | 251.00K |
| 233 | KYTX | Kyverna Therapeutics, Inc. | 472.99M | -2.02% | 1,286,553 | - |
| 234 | VALN | Valneva SE | 472.22M | 0.29% | 71,653 | 180.25M |
| 235 | EDIT | Editas Medicine, Inc. | 466.52M | -3.80% | 1,602,856 | 38.69M |
| 236 | OVID | Ovid Therapeutics Inc. | 464.73M | 1.22% | 1,156,952 | 7.12M |
| 237 | CABA | Cabaletta Bio, Inc. | 451.66M | 3.75% | 3,675,470 | - |
| 238 | EVMN | Evommune, Inc. | 448.43M | 3.84% | 861,584 | 10.00M |
| 239 | BNTC | Benitec Biopharma Inc. | 447.29M | 0.31% | 56,928 | - |
| 240 | PRLD | Prelude Therapeutics Incorporated | 442.33M | 1.59% | 211,223 | 16.72M |
| 241 | PRTA | Prothena Corporation plc | 441.34M | -2.43% | 504,691 | 57.94M |
| 242 | STRO | Sutro Biopharma, Inc. | 430.83M | -0.12% | 442,941 | 99.61M |
| 243 | PBYI | Puma Biotechnology, Inc. | 428.06M | 1.57% | 261,434 | 227.18M |
| 244 | EPRX | Eupraxia Pharmaceuticals Inc. | 426.44M | 2.84% | 133,812 | - |
| 245 | ANL | Adlai Nortye Ltd. | 425.20M | 15.54% | 136,099 | 5.00M |
| 246 | CCCC | C4 Therapeutics, Inc. | 420.16M | -0.26% | 4,016,179 | 34.86M |
| 247 | ABEO | Abeona Therapeutics Inc. | 415.49M | 3.26% | 1,254,430 | 14.54M |
| 248 | DMAC | DiaMedica Therapeutics Inc. | 411.67M | 2.83% | 161,577 | - |
| 249 | VTVT | vTv Therapeutics Inc. | 405.67M | 2.54% | 124,261 | 36.84M |
| 250 | HELP | Cybin Inc. | 403.52M | -2.54% | 766,161 | - |
| 251 | AUTL | Autolus Therapeutics plc | 401.88M | 4.14% | 1,442,552 | 92.62M |
| 252 | RCKT | Rocket Pharmaceuticals, Inc. | 398.56M | 0.27% | 1,712,970 | - |
| 253 | LRMR | Larimar Therapeutics, Inc. | 397.70M | 2.42% | 1,269,914 | - |
| 254 | UPB | Upstream Bio, Inc. | 395.63M | 1.82% | 332,111 | 3.32M |
| 255 | IPSC | Century Therapeutics, Inc. | 391.37M | 1.88% | 602,782 | 109.16M |
| 256 | AVIR | Atea Pharmaceuticals, Inc. | 388.93M | 3.40% | 194,590 | - |
| 257 | CMPX | Compass Therapeutics, Inc. | 385.39M | -2.28% | 1,685,245 | 850.00K |
| 258 | ENTA | Enanta Pharmaceuticals, Inc. | 384.71M | 0.92% | 101,202 | 69.21M |
| 259 | LXEO | Lexeo Therapeutics, Inc. | 372.19M | 2.60% | 772,115 | - |
| 260 | FENC | Fennec Pharmaceuticals Inc. | 368.21M | -5.02% | 188,381 | 51.00M |
| 261 | XFOR | X4 Pharmaceuticals, Inc. | 367.85M | -2.99% | 539,464 | 9.01M |
| 262 | PALI | Palisade Bio, Inc. | 352.37M | 5.18% | 2,547,308 | - |
| 263 | VNDA | Vanda Pharmaceuticals Inc. | 351.79M | - | 591,576 | 217.78M |
| 264 | IKT | Inhibikase Therapeutics, Inc. | 351.07M | - | 981,720 | 1.00 |
| 265 | FATE | Fate Therapeutics, Inc. | 348.51M | - | 1,934,471 | 6.32M |
| 266 | ZNTL | Zentalis Pharmaceuticals, Inc. | 340.27M | 0.21% | 677,788 | 26.87M |
| 267 | VCRE | Vicore Pharma Holding AB (publ) | 339.16M | -0.08% | 4,433 | 370.61K |
| 268 | IMRX | Immuneering Corporation | 333.84M | -0.96% | 526,165 | - |
| 269 | LYEL | Lyell Immunopharma, Inc. | 332.74M | 6.42% | 144,177 | 31.00K |
| 270 | FHTX | Foghorn Therapeutics Inc. | 319.99M | 1.30% | 246,643 | 28.22M |
| 271 | INDP | Indaptus Therapeutics, Inc. | 319.34M | 7.22% | 81,356 | - |
| 272 | GALT | Galectin Therapeutics Inc. | 313.48M | -10.86% | 529,032 | - |
| 273 | ELDN | Eledon Pharmaceuticals, Inc. | 310.76M | -0.74% | 1,236,184 | - |
| 274 | LCTX | Lineage Cell Therapeutics, Inc. | 304.14M | - | 590,929 | 14.78M |
| 275 | NMRA | Neumora Therapeutics, Inc. | 302.01M | 3.16% | 455,548 | - |
| 276 | OABI | OmniAb, Inc. | 301.54M | -2.80% | 384,065 | 28.94M |
| 277 | CNXU | Conexeu Sciences Inc. | 299.16M | 17.68% | 362,687 | - |
| 278 | IFRX | InflaRx N.V. | 297.53M | 0.50% | 450,347 | 33.82K |
| 279 | BCYC | Bicycle Therapeutics plc | 294.60M | 0.24% | 223,553 | 63.50M |
| 280 | IRD | Opus Genetics, Inc. | 287.33M | -2.25% | 667,327 | 11.98M |
| 281 | GLSI | Greenwich LifeSciences, Inc. | 286.81M | 2.79% | 46,619 | - |
| 282 | TTRX | Turn Therapeutics Inc. | 285.37M | -0.62% | 97,856 | - |
| 283 | NAGE | Niagen Bioscience, Inc. | 276.95M | 5.47% | 948,666 | 130.42M |
| 284 | SABS | SAB Biotherapeutics, Inc. | 276.80M | 0.56% | 368,862 | 114.70K |
| 285 | MGNX | MacroGenics, Inc. | 274.59M | 0.70% | 592,219 | 157.08M |
| 286 | ALXO | ALX Oncology Holdings Inc. | 273.16M | 1.50% | 669,826 | - |
| 287 | QTTB | Q32 Bio Inc. | 266.22M | -14.95% | 7,057,263 | 53.74M |
| 288 | TRDA | Entrada Therapeutics, Inc. | 256.20M | 4.56% | 282,714 | 5.74M |
| 289 | RNAC | Cartesian Therapeutics, Inc. | 255.03M | 0.70% | 180,454 | 1.78M |
| 290 | SRZN | Surrozen, Inc. | 252.99M | -0.41% | 139,703 | 7.49M |
| 291 | SLGL | Sol-Gel Technologies Ltd. | 252.42M | 2.42% | 31,117 | 18.47M |
| 292 | PRQR | ProQR Therapeutics N.V. | 249.79M | 4.12% | 447,993 | 15.73M |
| 293 | ADAG | Adagene Inc. | 242.49M | 1.66% | 42,024 | 7.67M |
| 294 | IVVD | Invivyd, Inc. | 240.69M | 2.02% | 1,742,330 | 55.87M |
| 295 | FULC | Fulcrum Therapeutics, Inc. | 237.21M | -0.84% | 1,019,092 | 80.00M |
| 296 | ACIU | AC Immune SA | 234.11M | -2.07% | 64,291 | 4.62M |
| 297 | AVXL | Anavex Life Sciences Corp. | 231.68M | 2.88% | 732,025 | - |
| 298 | TARA | Protara Therapeutics, Inc. | 231.56M | 0.73% | 300,558 | - |
| 299 | DTIL | Precision BioSciences, Inc. | 227.32M | 2.68% | 606,194 | 45.07M |
| 300 | CGEN | Compugen Ltd. | 223.22M | 2.61% | 207,142 | 72.66M |
| 301 | CHRS | Coherus Oncology, Inc. | 222.12M | -0.69% | 628,819 | 46.88M |
| 302 | NAUT | Nautilus Biotechnology, Inc. | 221.12M | -0.57% | 385,477 | - |
| 303 | CAMP | Camp4 Therapeutics Corporation | 218.61M | -5.39% | 121,863 | 3.93M |
| 304 | OBIO | Orchestra BioMed Holdings, Inc. | 218.56M | -1.08% | 188,560 | 32.72M |
| 305 | KROS | Keros Therapeutics, Inc. | 218.30M | 4.35% | 194,660 | 33.18M |
| 306 | KPTI | Karyopharm Therapeutics Inc. | 215.98M | -4.80% | 316,488 | 151.12M |
| 307 | NBP | NovaBridge Biosciences | 213.95M | 2.78% | 249,690 | - |
| 308 | RNA | Atrium Therapeutics, Inc. | 210.40M | 0.65% | 88,791 | 36.68M |
| 309 | AGEN | Agenus Inc. | 208.63M | -1.38% | 4,491,064 | 123.87M |
| 310 | WHWK | Whitehawk Therapeutics, Inc. | 207.07M | 1.05% | 355,380 | 7.15M |
| 311 | IMUX | Immunic, Inc. | 205.69M | 2.79% | 115,458 | - |
| 312 | CLLS | Cellectis S.A. | 202.12M | -2.26% | 9,181 | 75.11M |
| 313 | NERV | Minerva Neurosciences, Inc. | 201.26M | 7.46% | 186,920 | - |
| 314 | CDXS | Codexis, Inc. | 200.88M | 3.76% | 495,022 | 78.09M |
| 315 | VYGR | Voyager Therapeutics, Inc. | 193.35M | 1.27% | 627,586 | 36.49M |
| 316 | NKTX | Nkarta, Inc. | 190.31M | 0.38% | 893,578 | - |
| 317 | OTLK | Outlook Therapeutics, Inc. | 188.55M | -9.83% | 9,696,258 | 333.14K |
| 318 | KRRO | Korro Bio, Inc. | 187.93M | -1.81% | 133,107 | 3.84M |
| 319 | PLX | Protalix BioTherapeutics, Inc. | 187.73M | 0.87% | 576,680 | 76.38M |
| 320 | NRXP | NRx Pharmaceuticals, Inc. | 186.92M | 3.00% | 660,841 | 2.29M |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 185.07M | 4.97% | 362,290 | 17.56M |
| 322 | CNTN | Canton Strategic Holdings, Inc. | 184.32M | 3.91% | 630,614 | - |
| 323 | HUMA | Humacyte, Inc. | 183.79M | -3.62% | 3,982,367 | 2.02M |
| 324 | TNYA | Tenaya Therapeutics, Inc. | 182.97M | -2.48% | 1,835,847 | 225.00K |
| 325 | MDWD | MediWound Ltd. | 182.24M | -0.49% | 114,831 | 14.48M |
| 326 | ARCT | Arcturus Therapeutics Holdings Inc. | 181.62M | 0.31% | 377,756 | 54.71M |
| 327 | ACOG | Alpha Cognition Inc. | 180.73M | 3.11% | 50,869 | 10.83M |
| 328 | NGEN | NervGen Pharma Corp. | 179.48M | -2.87% | 1,322,812 | - |
| 329 | MIST | Milestone Pharmaceuticals Inc. | 172.78M | -2.31% | 760,230 | 1.78M |
| 330 | CRBU | Caribou Biosciences, Inc. | 171.58M | -1.14% | 1,215,026 | 11.20M |
| 331 | OKUR | OnKure Therapeutics, Inc. | 170.06M | -0.24% | 79,879 | - |
| 332 | MENS | Jyong Biotech Ltd. | 169.99M | 3.15% | 19,865 | - |
| 333 | IPHA | Innate Pharma S.A. | 169.14M | 0.56% | 3,057 | 10.57M |
| 334 | ANTX | AN2 Therapeutics, Inc. | 168.20M | -1.89% | 109,004 | - |
| 335 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 166.94M | -0.22% | 284,100 | - |
| 336 | ALEC | Alector, Inc. | 166.54M | 7.91% | 719,640 | 18.42M |
| 337 | ORMP | Oramed Pharmaceuticals Inc. | 166.16M | 1.50% | 155,297 | 2.00M |
| 338 | PEPG | PepGen Inc. | 166.01M | -1.64% | 1,822,773 | - |
| 339 | EQ | Equillium, Inc. | 165.65M | -5.07% | 552,085 | 4.39M |
| 340 | ABOS | Acumen Pharmaceuticals, Inc. | 160.35M | -12.25% | 676,191 | - |
| 341 | YDES | YD Bio Limited | 159.63M | 7.08% | 45,799 | 510.36K |
| 342 | CBUS | Cibus, Inc. | 158.77M | -12.97% | 669,822 | 4.29M |
| 343 | LENZ | LENZ Therapeutics, Inc. | 156.46M | 1.22% | 1,079,598 | 20.99M |
| 344 | PYXS | Pyxis Oncology, Inc. | 153.95M | 6.11% | 513,552 | 13.86M |
| 345 | KZIA | Kazia Therapeutics Limited | 153.58M | -0.22% | 182,626 | 1.27M |
| 346 | CNTB | Connect Biopharma Holdings Limited | 153.00M | 3.18% | 520,807 | 233.00K |
| 347 | MOLN | Molecular Partners AG | 151.16M | -2.25% | 1,610 | 856.30K |
| 348 | ARMP | Armata Pharmaceuticals, Inc. | 146.48M | 1.79% | 139,872 | 5.20M |
| 349 | AARD | Aardvark Therapeutics, Inc. | 145.52M | 6.55% | 186,500 | - |
| 350 | HURA | TuHURA Biosciences, Inc. | 145.20M | -4.20% | 313,100 | - |
| 351 | GUTS | Fractyl Health, Inc. | 144.37M | 13.75% | 12,172,634 | 3.00K |
| 352 | TLSA | Tiziana Life Sciences Ltd | 143.53M | -10.48% | 483,036 | - |
| 353 | UNCY | Unicycive Therapeutics, Inc. | 137.51M | -3.83% | 954,472 | - |
| 354 | GNLX | Genelux Corporation | 129.23M | 0.69% | 169,710 | 8.00K |
| 355 | ENGN | enGene Therapeutics Inc. | 127.28M | 0.26% | 813,163 | - |
| 356 | PMN | ProMIS Neurosciences, Inc. | 125.59M | 2.53% | 69,788 | - |
| 357 | SPRB | Spruce Biosciences, Inc. | 125.06M | -1.98% | 95,139 | 697.00K |
| 358 | FBIO | Fortress Biotech, Inc. | 123.24M | -0.54% | 742,235 | 66.16M |
| 359 | VANI | Vivani Medical, Inc. | 121.59M | 0.71% | 305,064 | - |
| 360 | CUE | Cue Biopharma, Inc. | 119.67M | -8.92% | 165,339 | 32.73M |
| 361 | ANIX | Anixa Biosciences, Inc. | 119.08M | 9.72% | 500,982 | - |
| 362 | SEER | Seer, Inc. | 118.76M | - | 310,397 | 15.17M |
| 363 | ALDX | Aldeyra Therapeutics, Inc. | 115.82M | -0.52% | 913,096 | - |
| 364 | KLRS | Kalaris Therapeutics, Inc. | 114.68M | 5.93% | 74,362 | - |
| 365 | PLYX | Polaryx Therapeutics, Inc. | 114.10M | 6.64% | 80,760 | - |
| 366 | COYA | Coya Therapeutics, Inc. | 113.53M | -0.62% | 256,614 | 7.94M |
| 367 | ONCY | Oncolytics Biotech Inc. | 107.90M | -0.46% | 918,314 | - |
| 368 | BDTX | Black Diamond Therapeutics, Inc. | 103.72M | -2.69% | 839,514 | 70.00M |
| 369 | PYPD | PolyPid Ltd. | 99.90M | -2.62% | 141,594 | - |
| 370 | SPRO | Spero Therapeutics, Inc. | 98.43M | - | 1,425,250 | 61.19M |
| 371 | VRCA | Verrica Pharmaceuticals Inc. | 97.23M | -4.55% | 30,885 | 37.16M |
| 372 | ICCC | ImmuCell Corporation | 97.07M | -8.45% | 49,467 | 29.93M |
| 373 | INO | Inovio Pharmaceuticals, Inc. | 96.26M | 0.86% | 616,377 | 65.34K |
| 374 | PTHS | Pelthos Therapeutics Inc. | 94.54M | 7.09% | 34,292 | 27.70M |
| 375 | ENLV | Enlivex Ltd. | 93.85M | -3.47% | 117,052 | - |
| 376 | BMEA | Biomea Fusion, Inc. | 93.27M | - | 577,351 | - |
| 377 | NTHI | NeOnc Technologies Holdings, Inc. | 91.80M | -3.80% | 141,659 | 39.99K |
| 378 | ACET | Adicet Bio, Inc. | 91.15M | -1.70% | 53,952 | - |
| 379 | MAIA | MAIA Biotechnology, Inc. | 89.38M | 2.08% | 524,073 | - |
| 380 | RNTX | Rein Therapeutics Inc. | 88.03M | 3.32% | 252,030 | - |
| 381 | ENTX | Entera Bio Ltd. | 87.74M | 9.88% | 300,723 | 42.00K |
| 382 | ATHE | Alterity Therapeutics Limited | 87.53M | -0.80% | 24,921 | 4.43M |
| 383 | NRXS | NeurAxis, Inc. | 86.44M | -2.38% | 38,260 | 4.28M |
| 384 | RLYB | Rallybio Corporation | 85.46M | 0.75% | 50,446 | 858.00K |
| 385 | CGTX | Cognition Therapeutics, Inc. | 84.94M | -6.03% | 1,364,384 | - |
| 386 | RANI | Rani Therapeutics Holdings, Inc. | 83.87M | 4.31% | 868,734 | 3.17M |
| 387 | TELO | Telomir Pharmaceuticals, Inc. | 83.22M | -2.42% | 33,754 | - |
| 388 | HRTX | Heron Therapeutics, Inc. | 83.09M | 2.12% | 3,046,347 | 150.71M |
| 389 | ACRV | Acrivon Therapeutics, Inc. | 82.18M | -9.86% | 545,425 | - |
| 390 | CSBR | Champions Oncology, Inc. | 80.27M | 2.12% | 9,503 | 57.95M |
| 391 | LONA | LeonaBio, Inc. | 80.13M | -10.40% | 21,716 | - |
| 392 | ALPS | Alps Group Inc | 79.54M | 0.13% | 71,974 | 3.74M |
| 393 | GOSS | Gossamer Bio, Inc. | 79.05M | 15.42% | 24,628,479 | 55.54M |
| 394 | OKYO | OKYO Pharma Limited | 78.19M | -5.70% | 547,836 | - |
| 395 | ATRA | Atara Biotherapeutics, Inc. | 77.04M | 6.34% | 73,447 | 23.14M |
| 396 | ANVS | Annovis Bio, Inc. | 76.58M | 5.26% | 465,300 | - |
| 397 | PMVP | PMV Pharmaceuticals, Inc. | 74.66M | -1.41% | 471,615 | - |
| 398 | HYFT | MindWalk Holdings Corp. | 74.00M | 0.68% | 167,330 | 20.70M |
| 399 | GANX | Gain Therapeutics, Inc. | 71.66M | - | 995,531 | - |
| 400 | IBIO | iBio, Inc. | 71.04M | -0.69% | 984,181 | 300.00K |
| 401 | XBIT | XBiotech Inc. | 69.82M | - | 21,253 | - |
| 402 | OSTX | OS Therapies Incorporated | 69.03M | -6.63% | 436,254 | - |
| 403 | MNOV | MediciNova, Inc. | 68.91M | 2.19% | 81,598 | 596.64K |
| 404 | PLRX | Pliant Therapeutics, Inc. | 68.82M | 2.75% | 347,537 | - |
| 405 | IMA | ImageneBio, Inc. | 67.79M | -0.17% | 1,513 | 800.00K |
| 406 | CING | Cingulate Inc. | 61.82M | -2.55% | 210,445 | - |
| 407 | EDSA | Edesa Biotech, Inc. | 61.09M | 1.93% | 21,086 | - |
| 408 | CRDF | Cardiff Oncology, Inc. | 60.80M | -32.11% | 12,709,465 | 525.00K |
| 409 | TCRX | TScan Therapeutics, Inc. | 60.33M | -0.74% | 473,755 | 9.14M |
| 410 | IMMP | Immutep Limited | 58.79M | 0.90% | 221,463 | 5.28M |
| 411 | ELTX | Elicio Therapeutics, Inc. | 57.98M | -2.25% | 745,613 | - |
| 412 | CNTX | Context Therapeutics Inc. | 57.91M | 1.19% | 1,214,243 | - |
| 413 | BOLD | Boundless Bio, Inc. | 55.48M | 0.41% | 137,820 | - |
| 414 | INKT | MiNK Therapeutics, Inc. | 55.25M | -2.80% | 10,478 | - |
| 415 | INMB | INmune Bio Inc. | 55.03M | 2.48% | 1,077,200 | 50.00K |
| 416 | XLO | Xilio Therapeutics, Inc. | 54.56M | 1.00% | 75,122 | 53.48M |
| 417 | VRXA | Veraxa Biotech AG | 53.46M | 1.44% | 179,764 | - |
| 418 | FLNA | Filana Therapeutics, Inc. | 53.14M | 0.92% | 225,295 | - |
| 419 | MCRB | Seres Therapeutics, Inc. | 52.78M | 2.06% | 30,992 | 1.15M |
| 420 | ATYR | aTyr Pharma, Inc. | 52.39M | 9.94% | 6,280,833 | 190.00K |
| 421 | MREO | Mereo BioPharma Group plc | 52.34M | 4.43% | 915,269 | 500.00K |
| 422 | BYSI | BeyondSpring Inc. | 52.22M | -4.51% | 24,898 | 1.88M |
| 423 | EXOZ | eXoZymes, Inc. | 51.89M | -12.57% | 11,901 | -700.00 |
| 424 | TIL | Instil Bio, Inc. | 51.68M | -2.56% | 4,915 | - |
| 425 | ELOX | Eloxx Pharmaceuticals, Inc. | 50.82M | 11.81% | 38,696 | - |
| 426 | RADX | Radiopharm Theranostics Limited | 49.61M | 0.70% | 41,665 | 10.86M |
| 427 | IBO | Impact BioMedical Inc. | 49.60M | -4.17% | 16,250 | 39.00K |
| 428 | MGX | Metagenomi Therapeutics, Inc. | 48.56M | -2.27% | 127,341 | 22.33M |
| 429 | DWTX | Dogwood Therapeutics, Inc. | 48.43M | 0.70% | 31,914 | - |
| 430 | HYPD | Hyperion DeFi, Inc. | 45.78M | 2.03% | 237,184 | 1.04M |
| 431 | DYAI | Dyadic International, Inc. | 44.46M | 0.83% | 254,811 | 3.81M |
| 432 | APLM | Apollomics, Inc. | 42.14M | 22.23% | 34,175 | 8.84M |
| 433 | PDSB | PDS Biotechnology Corporation | 41.64M | -0.80% | 327,873 | - |
| 434 | CRVO | CervoMed Inc. | 41.53M | -0.32% | 2,219,829 | 2.09M |
| 435 | ACTU | Actuate Therapeutics, Inc. | 41.15M | -0.58% | 272,516 | - |
| 436 | LTRN | Lantern Pharma Inc. | 39.55M | 0.98% | 96,291 | - |
| 437 | GRCE | Grace Therapeutics, Inc. | 39.55M | -1.22% | 116,881 | - |
| 438 | NNVC | NanoViricides, Inc. | 39.18M | -2.82% | 234,901 | - |
| 439 | VERU | Veru Inc. | 38.84M | 4.76% | 244,264 | 16.89M |
| 440 | RNXT | RenovoRx, Inc. | 38.77M | 1.13% | 90,761 | 1.49M |
| 441 | NTRB | Nutriband Inc. | 37.08M | 2.35% | 29,175 | 1.80M |
| 442 | ALGS | Aligos Therapeutics, Inc. | 35.71M | -5.56% | 65,308 | 4.71M |
| 443 | GNTA | Genenta Science S.p.A. | 35.39M | 20.00% | 237,345 | - |
| 444 | BCTX | BriaCell Therapeutics Corp. | 34.19M | 6.49% | 131,380 | - |
| 445 | LSTA | Lisata Therapeutics, Inc. | 34.15M | 1.08% | 71,569 | 170.00K |
| 446 | LITS | Lite Strategy, Inc. | 33.65M | -0.78% | 178,039 | - |
| 447 | ESLA | Estrella Immunopharma, Inc. | 33.21M | -5.43% | 29,478 | - |
| 448 | ABVC | ABVC BioPharma, Inc. | 32.35M | -4.48% | 111,819 | 797.92K |
| 449 | DARE | Daré Bioscience, Inc. | 31.01M | - | 92,519 | 1.16M |
| 450 | SER | Serina Therapeutics, Inc. | 29.25M | -6.70% | 74,236 | 130.00K |
| 451 | KYNB | Kyntra Bio, Inc. | 29.19M | -1.50% | 7,346 | 7.44M |
| 452 | ATNM | Actinium Pharmaceuticals, Inc. | 28.86M | 2.77% | 32,577 | 90.00K |
| 453 | PSTV | Plus Therapeutics, Inc. | 28.08M | -4.67% | 154,136 | 5.18M |
| 454 | TVRD | Tvardi Therapeutics, Inc. | 27.49M | -5.48% | 976,746 | - |
| 455 | GRDX | GridAI Technologies Corp. | 26.95M | 5.47% | 70,054 | - |
| 456 | IGC | IGC Pharma, Inc. | 26.81M | 0.34% | 238,135 | 1.11M |
| 457 | BRNS | Barinthus Biotherapeutics plc | 26.74M | 6.94% | 81,678 | 14.97M |
| 458 | EVAX | Evaxion A/S | 25.44M | 0.66% | 25,221 | 7.53M |
| 459 | NRSN | NeuroSense Therapeutics Ltd. | 25.41M | -1.52% | 53,336 | - |
| 460 | VYNE | VYNE Therapeutics Inc. | 25.25M | 6.50% | 2,194,514 | 454.00K |
| 461 | PLRZ | Polyrizon Ltd. | 24.47M | -5.01% | 23,411 | - |
| 462 | NXTC | NextCure, Inc. | 23.95M | 0.76% | 4,599,657 | - |
| 463 | MRKR | Marker Therapeutics, Inc. | 23.51M | -2.08% | 19,650 | 3.55M |
| 464 | CELU | Celularity Inc. | 22.58M | 3.31% | 23,476 | 26.55M |
| 465 | QNTM | Quantum BioPharma Ltd. | 21.68M | -2.58% | 53,908 | - |
| 466 | SKYE | Skye Bioscience, Inc. | 21.30M | -2.26% | 136,341 | - |
| 467 | NCEL | NewcelX Ltd. | 21.16M | -1.26% | 27,447 | - |
| 468 | AKTX | Akari Therapeutics, Plc | 21.13M | -10.06% | 27,771 | - |
| 469 | ATOS | Atossa Therapeutics, Inc. | 21.01M | 7.96% | 97,154 | - |
| 470 | CLRB | Cellectar Biosciences, Inc. | 20.86M | -0.76% | 788,466 | - |
| 471 | CVM | CEL-SCI Corporation | 20.10M | - | 302,518 | - |
| 472 | LGVN | Longeveron Inc. | 20.07M | 2.09% | 138,916 | 1.22M |
| 473 | TVGN | Tevogen Bio Holdings Inc. | 20.02M | -4.78% | 25,474 | - |
| 474 | LPCN | Lipocine Inc. | 19.46M | 2.16% | 23,735 | 2.00M |
| 475 | JSPR | Jasper Therapeutics, Inc. | 19.37M | -4.26% | 620,439 | - |
| 476 | KALA | KALA BIO, Inc. | 19.15M | 6.92% | 325,491 | - |
| 477 | NEUP | Neuphoria Therapeutics Inc. | 19.02M | -1.40% | 14,632 | -13.27K |
| 478 | PLUR | Pluri Inc. | 18.88M | 4.17% | 13,721 | 1.08M |
| 479 | ALLR | Allarity Therapeutics, Inc. | 18.77M | 1.72% | 81,277 | 345.00K |
| 480 | ICU | SeaStar Medical Holding Corporation | 18.58M | -3.75% | 42,855 | 1.44M |
| 481 | QNCX | Quince Therapeutics, Inc. | 18.17M | -3.68% | 39,601 | - |
| 482 | SNTI | Senti Biosciences Holdings, Inc. | 18.17M | -39.71% | 2,690,424 | 38.00K |
| 483 | PTN | Palatin Technologies, Inc. | 17.12M | 0.56% | 24,826 | 12.88M |
| 484 | HOWL | Werewolf Therapeutics, Inc. | 16.50M | -1.34% | 401,157 | 1.14M |
| 485 | KTTA | Pasithea Therapeutics Corp. | 15.97M | -0.81% | 400,501 | - |
| 486 | HIND | Vyome Holdings, Inc. | 15.93M | 4.13% | 29,298 | 152.72K |
| 487 | TPST | Tempest Therapeutics, Inc. | 15.84M | 9.13% | 269,237 | - |
| 488 | PASG | Passage Bio, Inc. | 15.75M | 10.59% | 57,777 | - |
| 489 | CYCN | Cyclerion Therapeutics, Inc. | 15.74M | -3.13% | 23,098 | 1.99M |
| 490 | MLEC | Moolec Science SA | 14.81M | -4.81% | 4,106 | 7.83M |
| 491 | OSRH | OSR Health, Inc. | 14.76M | 16.10% | 2,250,997 | 2.63M |
| 492 | CTXR | Citius Pharmaceuticals, Inc. | 14.58M | -0.17% | 117,516 | 5.61M |
| 493 | LEXX | Lexaria Bioscience Corp. | 14.58M | 0.15% | 18,230 | 194.00K |
| 494 | INAB | IN8bio, Inc. | 14.18M | 4.35% | 75,314 | - |
| 495 | LNAI | Lunai Bioworks Inc. | 13.51M | - | 26,570 | 20.94K |
| 496 | BIVI | BioVie Inc. | 13.35M | 12.03% | 285,842 | - |
| 497 | COCP | Cocrystal Pharma, Inc. | 13.24M | 2.10% | 32,410 | 225.00K |
| 498 | BLRX | BioLineRx Ltd. | 13.12M | -4.59% | 8,518 | 1.40M |
| 499 | INTS | Intensity Therapeutics, Inc. | 13.08M | -0.62% | 27,525 | - |
| 500 | GTBP | GT Biopharma, Inc. | 12.64M | -5.04% | 1,095,873 | - |